Published in
American Society of Hematology, Blood, 22(131), p. 2413-2425
DOI: 10.1182/blood-2017-11-812073
Links
Tools
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma
Journal article published in 2018 by
Valeria Spina,
Alessio Bruscaggin,
Annarosa Cuccaro 
,
Maurizio Martini,
Martina Di Trani,
Gabriela Forestieri,
Martina Manzoni,
Adalgisa Condoluci,
Alberto Arribas,
Lodovico Terzi-Di-Bergamo,
Silvia Laura Locatelli,
Elisa Cupelli,
Luca Ceriani,
Alden A. Moccia,
Anastasios Stathis
and other authors.
,
Maurizio Martini,
Martina Di Trani,
Gabriela Forestieri,
Martina Manzoni,
Adalgisa Condoluci,
Alberto Arribas,
Lodovico Terzi-Di-Bergamo,
Silvia Laura Locatelli,
Elisa Cupelli,
Luca Ceriani,
Alden A. Moccia,
Anastasios Stathis
and other authors.
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
Key Points ctDNA is as an easily accessible source of tumor DNA for cHL genotyping. ctDNA is a radiation-free tool to track residual disease in cHL.